Expert Review of Anticancer Therapy, Volume 22, Issue 2 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 22, Issue 2 (2022)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Volume 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives
Georgios D. Lianos, George A. Alexiou, Stefano Rausei, Vasiliki Galani, Michail Mitsis & Athanasios P. Kyritsis
Pages: 131-134
Published online: 15 Oct 2021
First Page PreviewforRepurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives | Full Text | References | PDF (156.1 KB) | EPUB
  • 2482 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Avelumab in locally advanced or metastatic urothelial carcinoma
Francesca Jackson-Spence, Bernadett Szabados, Charlotte Toms, Yu-Hsuen Yang, Christopher Sng & Thomas Powles
Pages: 135-140
Published online: 20 Jan 2022
AbstractforAvelumab in locally advanced or metastatic urothelial carcinoma | Full Text | References | PDF (261.1 KB) | EPUB
  • 451 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Understanding resistance to immune checkpoint inhibitors in advanced breast cancer
Paolo Tarantino, Romualdo Barroso-Sousa, Ana C. Garrido-Castro, Sandra S. McAllister, Jennifer L. Guerriero, Elizabeth Mittendorf, Giuseppe Curigliano & Sara M. Tolaney
Pages: 141-153
Published online: 28 Dec 2021
AbstractforUnderstanding resistance to immune checkpoint inhibitors in advanced breast cancer | Full Text | References | PDF (1.4 MB) | EPUB
  • 519 Views
  • 4 CrossRef citations
  • 0Altmetric
The impact of nutritional status on pancreatic cancer therapy
Gabriele Capurso, Nicolò Pecorelli, Alice Burini, Giulia Orsi, Diego Palumbo, Marina Macchini, Roberto Mele, Francesco de Cobelli, Massimo Falconi, Paolo Giorgio Arcidiacono & Michele Reni
Pages: 155-167
Published online: 12 Jan 2022
AbstractforThe impact of nutritional status on pancreatic cancer therapy | Full Text | References | PDF (383.2 KB) | EPUB
  • 626 Views
  • 1 CrossRef citations
  • 0Altmetric
Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer
Jun Suzuki, Masahiro Tsuboi & Genichiro Ishii
Pages: 169-182
Published online: 02 Jan 2022
AbstractforCancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer | Full Text | References | PDF (5.3 MB) | EPUB
  • 729 Views
  • 6 CrossRef citations
  • 0Altmetric
Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?
Danilo Rocco, Luigi Della Gravara, Nicola Franzese, Paolo Maione & Cesare Gridelli
Pages: 183-189
Published online: 20 Jan 2022
AbstractforChemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going? | Full Text | References | PDF (266.7 KB) | EPUB
  • 471 Views
  • 2 CrossRef citations
  • 0Altmetric
Current androgen receptor antagonists under investigation for resistant prostate cancer
Maria Concetta Nigro, Veronica Mollica, Andrea Marchetti, Michael Cheng, Matteo Rosellini, Rodolfo Montironi, Liang Cheng & Francesco Massari
Pages: 191-202
Published online: 28 Dec 2021
AbstractforCurrent androgen receptor antagonists under investigation for resistant prostate cancer | Full Text | References | PDF (1.6 MB) | EPUB
  • 610 Views
  • 4 CrossRef citations
  • 0Altmetric
Squamous cell carcinoma of the lung: improving the detection and management of immune-related adverse events
Lara Kujtan, Rama Krishna Kancha, Beth Gustafson, Lindsey Douglass, Christopher RH Ward, Blake Buzard & Janakiraman Subramanian
Pages: 203-213
Published online: 26 Jan 2022
AbstractforSquamous cell carcinoma of the lung: improving the detection and management of immune-related adverse events | Full Text | References | PDF (1.7 MB) | EPUB
  • 303 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Research

Article
Comparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study
Wenliang Bai, Jiaqi Zhang, Yanqing Wang, Mengxin Zhou, Lei Liu, Guige Wang, Ke Zhao, Xuehan Gao & Shanqing Li
Pages: 215-228
Published online: 21 Oct 2021
AbstractforComparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study | Full Text | References | PDF (1.3 MB) | EPUB
  • 238 Views
  • 1 CrossRef citations
  • 0Altmetric

Meta-analysis

Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis
Farah Latif, Hira Bint Abdul Jabbar, Hamna Malik, Humaira Sadaf, Azza Sarfraz, Zouina Sarfraz & Ivan Cherrez-Ojeda
Pages: 229-235
Published online: 24 Jan 2022
AbstractforAtezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis | Full Text | References | PDF (4.6 MB) | EPUB | Supplemental
  • 1675 Views
  • 8 CrossRef citations
  • 0Altmetric

Letter to the Editor

Article
Combination regimens and immunologic mechanisms to enhance the efficacy of cemiplimab for cutaneous squamous cell carcinoma
Hannah L. Hanania & Daniel J. Lewis
Pages: 237-238
Published online: 30 Dec 2021
CitationforCombination regimens and immunologic mechanisms to enhance the efficacy of cemiplimab for cutaneous squamous cell carcinoma | Full Text | References | PDF (155.1 KB) | EPUB
  • 921 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Targeted therapies in advanced biliary malignancies: a clinical review
Udhayvir S Grewal et al.
Review Article | Published online: 31 Jul 2024
Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 23 Jul 2024
Bevacizumab-containing treatment for relapsed or refractory Wilms tumor
Sarah Al-Jilaihawi et al.
Review Article | Published online: 23 Jul 2024
Understanding the link between aspartame and cancer
Morando Soffritti
Report | Published online: 31 Jul 2024
View all latest articles